JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Pan American Silver
PAAS
$18.6B
| $1.64M | ﹤0.01% |
105,419
-280,937
| -73% | -$4.45M |
2014 Q1
15 quarters
|
|
3277
Evertec
EVTC
$1.64B
| $1.64M | ﹤0.01% |
119,862
-40,582
| -25% | -$575K |
2013 Q2
18 quarters
|
|
3278
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.14B
| $1.64M | ﹤0.01% |
32,841
+7,108
| +28% | +$355K |
2015 Q1
11 quarters
|
|
3279
Citizens & Northern Corp
CZNC
$452M
| $1.63M | ﹤0.01% |
67,996
-4,024
| -6% | -$100K |
2013 Q2
18 quarters
|
|
|
WIRE
3280
DELISTED
Encore Wire Corp
WIRE
| $1.62M | ﹤0.01% |
33,373
+9,798
| +42% | +$453K |
2013 Q2
18 quarters
|
|
3281
J. Jill
JILL
$363M
| $1.62M | ﹤0.01% |
+49,543
| New | +$1.38M |
2017 Q4
0 quarters
|
|
3282
Insteel Industries
IIIN
$562M
| $1.62M | ﹤0.01% |
57,217
+2,518
| +5% | +$67.5K |
2016 Q4
4 quarters
|
|
3283
B2Gold
BTG
$6.83B
| $1.62M | ﹤0.01% |
522,368
+120,798
| +30% | +$326K |
2013 Q2
18 quarters
|
|
3284
CALL
Nektar Therapeutics
NKTR
$1.6B
| $1.61M | ﹤0.01% |
+1,800
| New | +$1.06M |
2017 Q4
0 quarters
|
|
3285
OFS Capital
OFS
$48.6M
| $1.61M | ﹤0.01% |
135,441
+44,329
| +49% | +$554K |
2017 Q2
2 quarters
|
|
3286
CALL
Deckers Outdoor
DECK
$10.8B
| $1.6M | ﹤0.01% |
+120,000
| New | +$1.44M |
2017 Q4
0 quarters
|
|
3287
VanEck Morningstar Wide Moat ETF
MOAT
$11.3B
| $1.6M | ﹤0.01% |
37,800
+35,095
| +1,297% | +$1.45M |
2017 Q2
2 quarters
|
|
|
GCAP
3288
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $1.6M | ﹤0.01% |
+160,305
| New | +$1.15M |
2017 Q4
0 quarters
|
|
|
VRN
3289
DELISTED
Veren
VRN
| $1.6M | ﹤0.01% |
210,176
+27,835
| +15% | +$210K |
2014 Q1
15 quarters
|
|
3290
Fabrinet
FN
$16.2B
| $1.59M | ﹤0.01% |
55,560
-68,673
| -55% | -$2.27M |
2015 Q1
11 quarters
|
|
3291
BOK Financial
BOKF
$7.68B
| $1.59M | ﹤0.01% |
17,254
+6,929
| +67% | +$611K |
2014 Q2
14 quarters
|
|
|
PDLI
3292
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.59M | ﹤0.01% |
581,580
-165,036
| -22% | -$507K |
2013 Q2
18 quarters
|
|
3293
CALL
Cardinal Health
CAH
$53.3B
| $1.59M | ﹤0.01% |
25,900
| – | – |
2017 Q3
1 quarter
|
|
|
3294
PUT
Cardinal Health
CAH
$53.3B
| $1.59M | ﹤0.01% |
25,900
| – | – |
2017 Q3
1 quarter
|
|
3295
Energy Recovery
ERII
$342M
| $1.58M | ﹤0.01% |
180,843
+2,931
| +2% | +$26.7K |
2013 Q2
18 quarters
|
|
3296
PUT
US Bancorp Series B Preferred Stock
USB.PRH
$733M
| $1.58M | ﹤0.01% |
29,500
-350,000
| -92% | -$8.04M |
2016 Q4
4 quarters
|
|
|
BPMC
3297
DELISTED
Blueprint Medicines
BPMC
| $1.58M | ﹤0.01% |
20,915
+9,639
| +85% | +$678K |
2015 Q2
10 quarters
|
|
|
ENIA
3298
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $1.58M | ﹤0.01% |
141,231
+90,387
| +178% | +$941K |
2015 Q4
8 quarters
|
|
3299
Barron's 400 ETF
BFOR
$231M
| $1.57M | ﹤0.01% |
+151,424
| New | +$1.54M |
2017 Q4
0 quarters
|
|
|
KLDX
3300
DELISTED
KLONDEX MINES LTD
KLDX
| $1.57M | ﹤0.01% |
601,851
+389,698
| +184% | +$1.11M |
2015 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.